COVID-19 Media Coverage

Dr. Phuong Vo explained clinical findings that could expand transplant access for people without a fully matched unrelated donor: “The patients experienced low incidence of GVHD, with no instances of severe chronic GVHD reported.”

Dr. Rachel Issaka and Fred Hutch patient Natalie Phelps discussed early onset colorectal cancer. Issaka said, “The number of people diagnosed in 1994 compared to 2024 has now doubled.” 

Dr. Masumi Ueda Oshima explained a clinical trial at Fred Hutch to prevent chronic GVHD. She said, “We think this regimen deserves further study in a multicenter fashion, and we are exploring some potential opportunities for that.”

Dr. Tom Lynch discussed how federal funding impacts cancer research: “Cancer research is done with federal funding, which is why the potential reduction in federal funding for science is so incredibly threatening to science throughout the country.”

Dr. Jesse Bloom commented on how rapidly SARS-CoV-2, the virus that causes COVID, evolves: "The speed at which it's undergone that evolution and the ability it's shown to undergo these big evolutionary jumps is really remarkable."

Dr. Tina Termini explained how her NIH-funded research helps people: "We are searching for better treatments for patients who have already succumbed to cancer who are already suffering from cancer.”

In a profile of Dr. Melody Campbell, she described her structural biology work as fun: “It’s always really rewarding to get a structure where you can see exactly where molecules are in relation to each other.”

In a Q&A, Dr. Thomas Lynch addressed oncology workforce changes: “Yes, it's got high pressure, it's got the same kind of burnout issues that so much of society has now. But oncology is special, particularly because of how the profession evolves.”

Fred Hutch patient Kaelyn Lukson spoke to the importance of biomarker testing to guide treatment: “If I had not received the test and been able to go on this treatment, I literally might not even be here.”

Dr. Steven Henikoff discussed his study published in Science, which showed how histone gene activity “could serve as a biomarker for tumor aggressiveness, complementing traditional histological assessments and improving cancer diagnosis.”

Dr. Anne McTiernan discussed the cancer risk associated with alcohol. She said, “There are several cancers that have increased risk for people that drink alcohol, including what used to be considered very small amounts of alcohol.”

Dr. Joe Unger reflected on how changes to clinical trials during the COVID pandemic “forced the sudden adoption of all of these procedures and, in my view, I think that their adoption is going to have a net positive impact on the entire system.”

In a story focused on reader questions about cancer, Dr. Kevin Cheung talked about metastasis. He said, “Much about how tumors metastasize — spread and take up residence in faraway sites – still remains a mystery.”

Dr. Megan Shen explained how her research has shown how people at the end of life appreciate simple pleasures. She said, “They finally figured out that the magic is trying to enjoy, right now while you have it, regardless of what that looks like.”

Dr. Rahul Banerjee described his research studies of a commonly used steroid: “We encourage future trials to investigate lowered-dose dexamethasone strategies prospectively, either at treatment onset or within a few cycles of treatment initiation." 

Dr. Paul Buckley spoke about Bridgette Hempstead, a Fred Hutch patient, research collaborator and advocate. He spoke about how Bridgette fought for “and everyone who was underserved. That was her issue. That was her purpose. That was her commitment.”

Dr. Joe Unger led a study on complications after prostate cancer treatment. He said: “It’s really important for men not just to understand how commonly these complications can occur, but how far out in time they are still meaningful.”

Dr. Anne McTiernan discussed the impact alcohol can have on cancer risk and why warning labels are helpful. She said, “If you get information out to people, then they can make their own choices about what might be healthier for them.”

Dr. Keith Jerome explained how dormant herpes infections can emerge “from this hiding place in the nerves... reactivate themselves and come back out, transmit to a new person or they can cause visible or sometimes painful lesions.”

Dr. Jesse Bloom commented on viral mutations found in a case of H5N1. He said, “It’s caught the attention of a lot of flu virologists, including myself, because some of the sequence has evidence of some of the types of mutations we worry about.”

Dr. Megan Shen described ways people can help loved ones diagnosed with cancer, including checking in and saying: “I'm thinking about you, I'm here to offer support in whatever way you want.”

Dr. Masumi Ueda Oshima discussed her Science Translational Medicine study showing how transplanted blood stem cells continue to form healthy new blood cells “even after many decades of transplanted donor cells making blood cells every day.”

Kelly Nelson spoke about the importance of sexual health support for breast cancer patients: “sexual health is a huge indicator of quality of life and mental and emotional well-being, and should be a priority for every patient.”

Dr. Larry Fong listed examples of new and upcoming cell therapies for solid tumors and described worldwide efforts to develop CAR T cells. He said: “The collective knowledge is growing at an accelerated pace.”

Dr. Christina Termini created an Atlas of Inspiring Hispanic/Latinx Scientists, hosted on Fred Hutch’s website, to connect and raise awareness of scientists from underrepresented groups. She commented: “We’re here and we’re not going anywhere.”

Drs. Ruth Etzioni and Scott Ramsey discussed multi-cancer early detection blood tests. Etzioni noted, “The future of screening is going to look different from the past” although “we’re not quite there.”

Dr. Larry Corey talked about the evolution of COVID noting, “The effects that the early vaccination had have long worn off, and the virus has escaped from them. The hope is double boosting will transfer your immunity.”

Dr. Lei Deng shared his thoughts on non-small cell lung cancer treatment data: “It is still not strong enough or definitive enough to make it standard of care to use dual checkpoint blockade for [patients with STK11 and/or KEAP1 mutations].”

Dr. Joe Unger pointed out that: “Federally sponsored, cancer clinical research has a unique role in identifying treatments that are best for patients. It’s not a role that can be supplanted by industry.”

Dr. Megan Shen summarized from her research of people facing serious illnesses that what people really want in life is “peace and love.” She added: “These are the only things that seemingly encompass all the other desires we have as humans.”

Dr. Jerry Radich explained his lab’s involvement in a new NCI-led effort to use genomics testing to screen patients. He said, “What we learn from myeloMATCH may have a major impact on the future of clinical trials in leukemia and beyond.”

Dr. Chris Li and peers discussed DEI in the cancer workforce at a recent policy summit. In recruiting a diverse pool of job applicants, Li urged others to “treat search as a verb.”

STAT included Miguel Paredes in the Bedford Lab and Yapeng Su in the Greenberg Lab in its Wunkerkinds awards to 27 of the “most impressive doctors and researchers on the cusp of launching their careers.”

Dr. Danielle Kirkey explained the balance of hope and reality when caring for patients. She said, "Anything we can do to give the best quality of life for as long as possible is always at the forefront of our mind.”

Dr. Brian Dontchos talked about dense breast classification: “Classification can vary depending on the doctor reading the mammogram because it’s somewhat subjective.” The story was syndicated in several news outlets.

Drs. Keith Jerome and Marius Walter discussed their Nature Communications study on gene editing for herpes. Jerome explained his hope for a herpes cure: “You don’t ever have to worry about this virus again.”

Fred Hutch patient Kaley Karaffa and Dr. Josh Hill explained how being immunocompromised impacts daily life. Karaffa said, “I had to become cautious about who I saw, the activities I was involved in and even the kind of food I ate.”

Dr. Ming Yu explained how aging cells that accumulate in the body can create a “tumor-promoting microenvironment,” but a certain drug may be able to eliminate these “zombie cells” and prevent them from developing into cancer.

Dr. Thomas Lynch discussed the newly formed Cancer AI Alliance: “What was interesting about this whole process was how we were able to bring together these four incredible cancer centers, and these four major tech companies.”

Dr. Jesse Bloom explained how virus mutations could change the accuracy of serology tests for infections: "This type of mutation could make you want to then redo the assays with a virus that contained that mutation.”

Dr. Joe Unger explained the scale of the cancer clinical trial funding gap: “We recognized that industry was playing an increasing role in cancer clinical research compared to decades ago. But we didn't realize the difference was this dramatic.”

Dr. Jesse Fann explained the negative impact of keeping a cancer diagnosis private: “In the long term, holding emotions back without an outlet can lead to an increase in stress, anxiety, depression, [and] social isolation.”

Drs. Denise Galloway and Nina Salama discussed how HPV and H. Pylori can cause cancer. Galloway said, “If you vaccinate someone who’s young, the risk goes down to zero.”

Dr. Megan Shen wrote about how to improve communication about pain between patients and their health care providers: “Addressing this vulnerable group’s pain needs is a critical public health concern.” 

Fred Hutch’s announcement of the acquisition of three buildings in South Lake Union, including the Steam Plant, was featured. It noted the change from building a new facility on campus to instead acquiring the space. 

Dr. Rahul Banerjee explained symptoms of multiple myeloma and treating the disease with CAR-T. He said, “Cancers of the immune system often know all the tricks of the immune system and are able to bypass them. With CAR-T, you level the playing field.”

Dr. Larry Corey recommended everyone eligible for the COVID vaccine update get one. He said, “When we look at people who are currently hospitalized, they haven’t been boosted for a long time.”

Dr. Veena Shankaran highlighted how financial strain impacts patients: “Cancer affects work, income, depletes savings, changes the way you spend your money, contributes to debt, and may affect how you plan financially for your family members.”

Kelly O’Brien was quoted in this story which highlighted the record-breaking Obliteride turnout. She said, “Obliteride brings together a powerful, one-of-a-kind community.”

Dr. Jennifer Adair explained the need for gene therapy clinical trials to include people from different populations around the world. Otherwise, she said: “we’re killing time thinking that we’ve got something that’s going to be a one shot fits all.”

Dr. Bill Grady commented on new tests to detect circulating tumor DNA in blood: “There is a lot of work going on in the field of blood-based cancer screening tests to improve on their current accuracy.

Brian Minalga discussed the lack of health data about trans people: “Even though trans people are participating in clinical research and giving our biospecimens, our blood, our tissues, our time... [those data] don’t make it back to us.”

Dr. Rahul Banerjee recommended that patients ask their oncologists for trusted sources of information. He said, “I think patient support groups for my patients have been tremendously important because they learn from each other.”

Dr. Bill Grady emphasized: “What breaks my heart is that it’s preventable. One of my biggest joys is when I’m doing colonoscopy and I can take out polyps.” Grady was also quoted in stories in Axios, CNN, MedPage Today and VeryWell Health.

Dr. Jim Kublin characterized an effective HIV vaccine as the “holy grail of HIV prevention.”

Dr. Lisa Newcomb commented on her recent study of active surveillance for prostate cancer. She said, “These results demonstrate active surveillance as an effective management strategy for patients diagnosed with favorable-risk prostate cancer.”

Dr. Elizabeth Loggers spoke about cancer treatment and fertility: “After you start treatment, you may already have some lasting effects on your fertility. It is important to have that conversation upfront and to act if it is important to you.”

Dr. Lindsay Gunnell explained why skin cancer rates are increasing in Washington: “There's a false sense of security here with our cloud cover that we're getting protection.”

Dr. Kemi Doll discussed the results of her JAMA Oncology study saying, “These findings suggest that the transvaginal ultrasonography triage strategy is not reliable among Black adults at risk for endometrial cancer.” Medscape also covered the study. 

The Cancer Letter highlighted Science Education’s new program, Partners in Science 2.0, along with other summer programs at Fred Hutch that aim to educate students and teachers. 

Ro Yoon and Dr. Larry Corey shared perspectives on HIV research, activism and public fatigue. Yoon emphasized the importance of keeping HIV “relevant to an audience that might not be aware of the long, hard history of activism.”

Dr. Yaw Nyame encouraged men in their 40s to discuss cancer screening with their doctors. “That routine of going in annually having to check up, discussing preventative health,” he said, “unfortunately, that’s not the norm for a lot of men.”

Dr. Stephanie Lee advocated for having “quality of life” be an endpoint in cancer treatments, along with survival. She said: “It's not just survival. If you look at FDA parlance, it's length of life and it's quality of life.”

Dr. Mazyar Shadman discussed CAR-T vs. standard of care for large B-cell lymphoma patients: “CAR-T remains to be standard of care for patients who are eligible and if they have access to it.” 

Dr. Keith Jerome discussed his team’s progress in developing a gene therapy for herpes simplex virus. He said, “There’s not a cure yet that everybody can go out and get, but we’re getting closer to a cure.”

Dr. Sara Hurvitz discussed three breast cancer studies presented at ASCO, “this was an exciting conference, with a large amount of data out.” The three abstracts discussed were  DB-06, postMONARCH and INAVO120 study.

A feature on leaders in cancer clinical trials included Drs. Garnet Anderson, Ruth Etzioni, Ziding Feng, Katherine Guthrie, Charles Kooperberg and Scott Ramsey for their work on the new Cancer Screening Research Network, based at Fred Hutch.

Dr. Chris Li explained: “I felt a responsibility to try and enhance the diversity of our faculty more broadly and provide some of that mentorship and sponsorship that I think could help promote further diversity in science.”

Dr. Elizabeth Loggers discussed the benefits of offering patients palliative care virtually: “They can be at home, in their pajamas, and their caregivers or anyone else across the country can sit in on that appointment to act as support.”

Dr. Keith Jerome described how his team’s herpes cure research could help people who want to be cured of their infection: “What we want to do is offer a tool that says if this really matters to you, we can help make your life better.”

Dr. Lisa Newcomb discussed active surveillance for prostate cancer in her new study: “We hope that this study encourages the national acceptance of active surveillance instead of immediate treatment for prostate cancer.”

Dr. Pavitra Roychoudhury described how researchers sequenced a bird flu genome from store-bought milk, noting that “this is, to our knowledge, the first time it’s been done in commercially available milk, to obtain the full genome.”

Dr. Scott Ramsey emphasized that cancer patients who file for bankruptcy have an 80% higher risk of dying from cancer than patients who don’t file. He said, “There actually was a pretty big detriment for survival.”

Dr. Trevor Bedford noted that “separate from the sequencing for evolution [of the virus], which I think is very important, just even understanding prevalence through space and time... would be really helpful and important.”

Louis Shackleford emphasized that “the prospect of having a vaccine that can last for years and give us sustained protection from HIV would be an amazing boon for communities such as the Black community who disproportionately are suffering from HIV.”

Dr. Janie Lee discussed how early screening saves lives: “And increasingly now, there's information that screening in the 40s also reduces breast cancer as well."

Dr. Joe Unger and collaborators pointed out that in their study of cancer clinical trial participation, “these results suggest that contributions to clinical research for adults with cancer is more common than is typically realized.”

Dr. Neel Bhatt and co-authors found lower employment rates in adult survivors of childhood cancer, suggesting “a multidisciplinary approach involving survivors, clinicians, and employers” is needed to address their long-term employment needs.

Dr. Jennifer Adair discussed her work with collaborators across the globe and the challenges of gene therapy access. She also said, “I would love to see patients engaged as co-creators in these medicines in much more meaningful ways.”

Dr. Jesse Bloom shared context amidst ongoing concerns about the H5N1 virus: “H5N1 has been circulating in various species and causing sporadic human infections for over two decades, and so far we haven’t had a pandemic.” 

Dr. Janie Lee commented on new breast cancer screening guidelines. She said they would help create “less confusion among women about breast cancer screening” and that “the scientific evidence is clear mammography saves lives.”

In an editorial, Dr. Hans-Peter Kiem praised success in gene therapies and called for more research in in vivo gene therapy to enable expanding “the availability away from specialized centers.”

Dr. Chris Johnston described next steps for work published in Nature with Dr. Susan Bullman: “Because this bacterium is so intimately associated with cancers, it raises the question, ‘can we harness this?’ That’s something we’re very interested in.”

Dr. William Grady explained the limitations of new blood tests for cancer noting they are “not effective for brain cancer because brain cancer spreads rapidly, even when early and very small, so it is not often curable even at an early stage.”

Dr. Ming Yu discussed research of therapies that “cause ‘zombie cells’ to die without harming normal cells” as having potential “not only to help people live longer, but also live healthier and hopefully cancer-free.”

Dr. Joe Unger underscored that “as we work to increase participation in cancer research studies and make them more accessible to patients, we need an inclusive, accurate assessment of current participation to inform these policies.”

Dr. Rahul Banerjee encouraged use of minimal residual disease to guide multiple myeloma treatments. He said, “I would be very excited about trials that use MRD as an endpoint to get more drugs to our patients sooner.” He also spoke with Endpoints.

Dr. Megan Shen shared tips on how parents can support their adult children who are coping with cancer. She emphasized communication, since an “an adult cancer patient’s needs ‘can be wildly different from one child to the next.’”

Natalie Phelps, a patient with colorectal cancer, advocated for lowering the screening age: “lowering the age from 50 to 45 for the start of (having a) colonoscopy is a good step in the right direction. I’d like to see it lowered even more.”

Matthew Triplette discussed trends in people younger than age 50 getting cancer, and how he doubts there’s “some new, very dangerous cancer risk factor out there that’s causing tons of excessive cases in younger folks.”

Fred Hutch’s Hanako Osuga received the GeekWire award for her work with the Coding for Cancer program, which helps students from underrepresented groups in STEM get experience with computing skills in biomedicine.

Dr. Jesse Bloom explained how researchers are studying how coronavirus works as populations have immunity to it. He said, “The virus is still evolving, it’s still infecting large numbers of people. We need to keep tracking this.”

Dr. Susan Bullman explained a new Nature study she co-authored with Dr. Chris Johnston and how a specific subtype of bacterium helps tumor cells hide from therapies: “It acts like a cloak.” Many medical and health news outlets also covered the study.

Dr. Rachel Issaka noted: “If people have more options that are convenient for them, they are more likely to participate in colon cancer screening, and we can pick up earlier cases where treatments are most effective.”

Dr. David Maloney explained the work he did in the 1990s to develop antibodies targeting cancer. He said, “With this approach, it was one antibody that was only good for one patient. You had to make an antibody for essentially every patient.”

Dr. Bill Grady commented on results from a study he led of a new blood test for colorectal cancer, emphasizing that “more screening should result in fewer cancer deaths.” This story ran in local outlets across the U.S.

Dr. Bill Grady explained that colonoscopies and “stool-based tests have that kind of ‘ick’ factor related to them. We need to find tests that people are going to use.”

Denene Prophet-Williams, MBA, MLA, BSN, is featured as Fred Hutch’s newly-named vice president and chief nursing officer. The Cancer Letter and GeekWire also covered the news. 

Dr. Rachel Issaka stressed the importance of prevention and screening: “March is colorectal cancer awareness month, and colon cancer is one of the most common cancers. But we can all do things to reduce our risk.”

Dr. Julie McElrath declared in a plenary talk at CROI that “An HIV vaccine could end HIV. So I say, ‘Let’s just get on with it.’”

Dr. Yunda Huang discussed HIV vaccines at CROI: “I've been working in this field for 20 years now and there is a misconception that with pre-exposure prophylaxis, our job is done, but HIV is so far  away from being solved.”

Dr. Janice Kim commented on a new study to treat triple-negative breast cancer.

Dr. Christopher Kemp discussed using lab tests of existing drugs on patients’ tumor cells to see which treatment works best.

Dr. Jonathan Bricker shared his motivation to create QuitBot.

Dr. Ruth Etzioni gave context to breast cancer incidence rates.

Dr. Petros Grivas discussed the different bladder cancer types.

Dr. Bill Grady explained why earlier screening is not covered by insurance.

Dr. Jesse Fann shared insight as to why some people choose to keep their cancer diagnosis private.

Dr. Jim Boonyaratanakornkit encouraged people to get vaccinated for COVID, flu and RSV.

Dr. Kleber Fertrin discusses the significance of new treatments.

Dr. Jesse Bloom said it is too early to say whether the latest COVID variant called JN.1 will cause surges of infections.

Dr. Megan Shen listed reasons why the holiday season can trigger grief. 

Dr. Sara Hurvitz received substantial media attention for HER2CLIMB-02 trial results she presented at the San Antonio Breast Cancer Symposium.

Dr. Megan Shen discussed how open conversations can improve how people cope with grief, pain and other challenges.

Dr. Julie Overbaugh commented that “many people probably have very low levels of potential tumor cells in the body that are kept at bay by the immune system.

Dr. Daniel Blanco-Melo was named a Science News “Scientist to Watch.”

Dr. Matty Triplette discussed new expanded guidelines for lung cancer screening.

Dr. Josh Hill pointed out the need for preventive COVID-19 therapies. 

Dr. Nina Salama explained the biology of the bacteria H. pylori.

Dr. David Maloney discussed CAR T-cell therapy for treating CLL.

Dr. Joe Unger found that the Medicaid expansion of the Affordable Care Act enabled many low-income individuals to become eligible for Medicaid.

A news brief covered the Fred Hutch announcement of Dr. Lawrence Fong joining Fred Hutch.

Dr. Jerry Radich described the substantial progress in diagnosing and treating CML.

Dr. Riha Vaidya and collaborators commented on clinical trial access. 

Dr. Larry Corey said we can honor Dr. Stephaun Wallace “not only in developing safe and effective vaccines against HIV and COVID, but in seeing the equitable distribution and accessibility of these vaccines globally. He would expect no less of us.”

Coverage of First Lady Jill Biden's visit to Fred Hutch appeared on the front page. 

A new study led by Dr. Burcu Darst could change gene panel testing.

Hanako Osuga, Coding for Cancer program lead, commented on the importance of the program.

Dr. Phil Greenberg, president of AACR, expressed optimism for some cancers.

In a brief, The Cancer Letter covered the announcement of Fred Hutch’s leadership of a new Asian American, Native Hawaiian and Pacific Islander cohort study.

Dr. Motoko Koyama described her study on the microbiome.

Dr. Joe Unger emphasized that findings from a study.

Dr. Harmit Malik commented on a new study identifying how certain genes that help us survive also can harm us.

Dr. Marianne Dubard-Gault emphasized the importance of health providers providing context to people who get health screenings.

Dr. Amanda Paulovich described her new study to better improve treatment for ovarian tumors.

The Biden administration named Dr. Matthew Triplette a cancer moonshot scholar.

The Science Education Program was featured. 

Dr. Rachel Issaka shared her experience as a clinician.

In a podcast, Dr. Jesse Bloom commented on how he got interested in hte covid pandemic origins. 

Dr. Fred Appelbaum explained how bone marrow transplantation has led to other treatments.

Dr. Yaw Nyame and his patient, Floyd Gossett, spoke about the importance of Black men getting screened for prostate cancer.

Dr. Veena Shankaran discussed financial toxicity.

Dr. Aaron Ring commented on his move to Fred Hutch.

In a podcast and Q&A, Dr. Fred Appelbaum spoke of his newly published book on Dr. Don Thomas’s life and research.

Dr. Rachel Yung commented on new mammogram guidelines. 

Dr. Stacey Cohen commented on a study of an experimental AI tool.

Dr.  Holly Harris commented on her new study looking at ovarian cancer risk. 

Dr. Larry Corey discussed the current approach in HIV vaccine research.

Dr. Jesse Fann discussed the importance of screening for depression among cancer patients.

Dr. Larry Corey discussed HIV vaccine research. 

Dr. Eric Holland discussed a new study to understand side effects of immunotherapies.

Dr. Bill Grady emphasized the importance of colon cancer screening.

Dr. Rachel Issaka pointed out health disparities in colorectal cancer survival.

A story on the opening of the new clinical space at Fred Hutch.

Dr. Christoph Lee commented on the new dense breast disclosure requirements. 

Dr. Megan Shen discussed her work with families making health care decisions.

Dr. Cyrus Ghajar discussed the vision for MET-X.

Dr. Joe Unger explained additional benefits of publicly-funded cancer clinical trials.

Dr. Delphine Chen shared her thoughts on the use of radioligand therapy.

Saiyare Refaei shared details about their partnership with Fred Hutch’s PACD program.

Dr. Shaveta Vinayak commented on progress by Dr. Nora Disis’ team on therapeutic breast cancer vaccines.

Dr. Kristin Anderson explained why mesothelin is a high-priority target for solid tumor cell therapies.

Dr. Jesse Bloom put XBB.1.5  into context with virus evolution.

Dr. Jesse Bloom commented on mutations that make XBB.1.5 different from the omicron variant.

Kathy Surace-Smith was featured among six Seattle philanthropists.

A feature story on COVID-19 variants and implications for vaccines cited a 2021 study led by Dr. Jesse Bloom.

Dr. Molly Tokaz shared additional insights about her research presented at ASH 2022.

Hilary Hehman commented on the program. 

Dr. Ulrike Peters commented on her Nature Genetics paper.

Dr. David Dean commented on issues in oral health, including cavities and dry mouth, following cancer treatment.

Dr. Hong Xiao pointed out that his analysis found health disparities and “trials’ failure to report certain demographics, despite federal requirements.

Dr. Julie McElrath explained the germline targeting vaccine approach.

Dr. Larry Corey underscored that implementation of vaccines is important. 

Dr. Trevor Bedford explained that vaccines and infections from earlier SARS-CoV-2 variants created the initial niche for omicron to spread.

Dr. Steve Pergam gave practical guidance for managing risk of infection as an immunocompromised person.

Dr. Stephaun Wallace explained how lack of data on transgender people living in WA leads to health inequities.

Dr. Mazyar Shadman commented on a clinical trial for a CAR T-cell therapy that was developed at Fred Hutch to target CD20 protein on cancer cells. 

Dr. Alpana Waghmare discussed how existing treatment options are less effective against new COVID variants.

Dr. Anne McTiernan recommended a reasonable approach to limiting ultraprocessed foods.

Dr. Larry Corey urged the development of new COVID drugs and vaccines.

Dr. Alpana Waghmare commented on rising cases of respiratory illness this fall and winter.

Dr. Megan Shen shared tips on avoiding burnout.

Dr. Jesse Bloom commented on how COVID variants could change in the fall and winter.

Dr. Thomas Lynch commented on the Bezos family gift. 

Coverage of the Bezos family gift to Fred Hutchinson Cancer Center. 

Dr. Heather Greenlee discussed new guidelines issued by SIO/ASCO on non-drug cancer pain treatments.

Dr. Janice Kim spoke about radiation therapy for breast cancer and what patients need to know about therapies and effects on the body.

Dr. Trevor Bedford projected that COVID-19 will infect roughly 50% of people in the U.S. each year.

Drs. Michael Emerman and Daniel Blanco-Melo discussed how viruses work their way into genomes and over time no longer infect others.

Dr. Jim Boonyaratanakornkit shared advice for how caregivers can help prevent infection when a loved one is receiving treatment.

Kelly O'Brien commented on what the $78 million gift for precision oncology will mean for Fred Hutch. 

More than more than 80 physicians, physician assistants and nurse practitioners were included in the Seattle Met Magazine’s 2022 Top Doctors list.

Dr. Aakanksha Singhvi discussed the biological changes in the brain during aging, including interactions between types of brain cells.

Dr. Hannah Linden discussed endocrine therapy.

Dr. Larry Corey joined Jake Whittenberg for a bike ride and then sat down to discuss lessons learned during COVID.

Dr. Will Gwin provided commentary about the recently FDA-approved treatment for HER2-Low breast cancer.

Seattle Met recognized bone marrow transplantation advanced by Fred Hutch as one of the top medical innovations developed in the region.

Dr. Holly Harris commented on her study on the link between psoriasis, psoriatic arthritis and endometriosis.

Dr. Nina Salama discussed H. pylori. 

Dr. Trevor Bedford commented that a virus’s ability to mutate around our immune defenses can continue indefinitely.

Highlights from Dr. Anthony Fauci and Dr. Larry Corey’s fireside chat was covered as well as the presentation of the honorary Hutch Award.

The presentation of the honorary Hutch Award to Dr. Anthony Fauci at the Mariners game was covered. 

Arlyce Coumar, an advanced practice nurse at Fred Hutch, commented on the importance of advocacy for oncology nurses. 

Kathryn Kistler of the Bedford lab and Dr. Jesse Bloom discussed how SARS-CoV-2 will keep evolving.

Dr. Stephaun Wallace provided context around rising HIV infections globally.

Dr. Jesse Bloom agreed with F.D.A. recommendations for the COVID vaccine to be updated based on Omicron, despite ongoing evolution of the virus.

Dr. Stephaun Wallace commented on monkeypox risk.

Dr. Gabriela Chiorean described new findings in chemotherapy and radiation regimens for people with advanced pancreatic cancer.

Drs. Jesse Bloom, Trevor Bedford and other experts encourage updating covid vaccines to protect against Omicron subvariants.

Seattle Magazine featured Fred Hutch scientists Drs. Phil Greenberg, Denise Galloway, E. Gabriela Chiorean and Petros Grivas in an article about doctors who continue to make Seattle a hotbed of cancer research and treatment.

Dr. Melody Campbell is listed as one of the 22 Pew scholars.

Dr. Liz Duke explained a study of antivirals to prevent COVID.

Dr. Joe Unger commented on a study he led on treatment-associated adverse events by sex.

Dr. Larry Corey compared the challenge of developing effective HIV vaccines with raising children.

Dr. Josh Veatch discussed a New England Journal of Medicine study about a T cell receptor therapy for pancreatic cancer.

Dr. Jonathan Bricker discussed smoking cessation.

Dr. Catherine Liu and Rebecca Relyea, a patient, discussed a monoclonal antibody drug that prevents COVID in people who are immunocompromised.

Dr. Phil Greenberg commented on his recent AACR election.

Drs. Josh Schiffer and Trevor Bedford shared COVID-19 insights.

Dr. Rachel Bender Ignacio advocated for expanded access to COVID antivirals.

Dr. Joe Unger shared his hopes for the treatment of cancer patients. 

A STAT special report noted Dr. Trevor Bedford’s COVID predictions.

Dr. Heather Greenlee discussed her new study on breast cancer and cardiovascular risk.

Drs. Tom Lynch and Paul Ramsey describe unified adult cancer care.

Dr. Tom Lynch spoke about Fred Hutch’s growing catchment area and how to serve populations across WA state.

Drs. Paul Ramsey and Tom Lynch discuss the cancer care restructure.

Dr. Steven Henikoff discussed new Science papers detailing gaps in the human genome, including on centromeres.

Dr. Bloom and Dr. Starr study virus evolution.

Dr. Veena Shankaran and coauthors urged more support for people with cancer.

Dr. Josh Schiffer reflected on the evolving nature of the pandemic.

Dr. Larry Corey commented on longer-term immune data on the J&J COVID vaccine.

Dr. Joe Unger discussed future research building on a study he led.

Dr. Josh Schiffer recommended a flexible approach to SARS-CoV-2 measures going forward.

Dr. Elizabeth Halloran shared her thoughts on COVID-19 outlook in the U.S.

Dr. David Maloney commented on a report of long term remissions with CAR T-cell therapy.

Dr. Marie Bleakley discussed her work on naive T cells and graft-vs-host disease.

Drs. Michele Andrasik and Stephaun Wallace discussed diversity in vaccine trials.

Drs. Josh Schiffer, Pavitra Roychoudhury and Trevor Bedford shared omicron insights.

Dr. Elizabeth Duke explained how COVID antivirals work.

Dr. Veena Shankaran shared findings from a recent study.

Dr. Trevor Bedford shared predictions about omicron.

Dr. Trevor Bedford discussed the Seattle Flu Study and tracking viruses in a Bloomberg mini-documentary on genomic surveillance.

Drs. Elizabeth Halloran and Larry Corey described decades of scientific effort that led to COVID vaccines.

Dr. Jesse Bloom and other experts call for new standards for data transparency.

Travel, language and barriers are all barriers to CAR T treatment, Dr. Anurekha Hall explained from findings she presented at ASH.

Hilary Hehman described the Pacific Northwest’s growing biotech role.

Dr. Sylvia Lee emphasized early detection in the treatment of melanoma.

Dr. Josh Schiffer compared omicron to previous variants.

Dr. Larry Corey highlighted the strain on hospital systems.

Dr. Josh Schiffer characterized recent COVID variants.

Dr. Trevor Bedford shared insights in a Q&A, including updating COVID vaccines to circulating variants.

In a Q&A, Dr. Trevor Bedford discussed the rapid rise of omicron and challenges in detecting cases.

Dr. Trevor Bedford joined a press briefing on omicron. 

Dr. Jennifer Lund explained the immune response to COVID.

Dr. Larry Corey talked about the complexity of COVID, quarantines and young children.

Dr. Trevor Bedford and Andy Slavitt discussed omicron.

Dr. Trevor Bedford predicted a coming wave of omicron infections.

Dr. Andrew Hsieh gave an overview of bladder cancer and what treatments are on the horizon.

Dr. Jesse Bloom and a coauthor answered questions about omicron.

In a profile, Dr. Shivani Srivastava talked about how she first got interested in immunology.

Dr. Josh Schiffer described his concerns about omicron infections.

In an omicron-focused Q&A, Dr. Trevor Bedford mentioned how to prevent future variants.

Dr. Trevor Bedford commented on genomic surveillance of SARS-CoV-2.

Dr. Larry Corey answered viewer questions about omicron, including vaccine efficacy.

Dr. Elizabeth Halloran talked about implications of the latest COVID-19 variant.

Dr. Trevor Bedford discussed omicron’s evolutionary path.

Dr. Trevor Bedford discussed early reports of spread of the omicron variant. 

Drs. Larry Corey and Pavitra Roycoudhury discussed the Omicron variant.

Dr. Trevor Bedford explained how omicron differs from other gradually evolving strains of SARS-CoV-2.

Dr. Trevor Bedford spoke on sequencing of variants. 

Dr. Josh Schiffer noted that larger data sets are needed to understand omicron.

Dr. Julie McElrath provided context about subunit protein vaccines, like those made by Novavax and Sanofi.

Kelly O’Brien discussed crypto donations to Fred Hutch, which is limited at this point but an important new way to reach donors.

Dr. Larry Corey reflected on how COVID will change our response to respiratory illnesses.

Dr. Elizabeth Halloran commented on COVID-19 immunity in the U.S.

Dr. Trevor Bedford’s recent Twitter thread on how SARS-CoV-2 might continue to evolve was featured. 

Dr. Michele Andrasik noted that HVTN and CoVPN’s experience in engaging diverse communities in vaccine studies can support other areas of research.

Kathy Briant and Dr. Rachel Issaka discussed how the pandemic has reduced cancer screenings.

Dr. Tyler Starr received a STAT Wunderkind award for his research on SARS-CoV-2 evolution.

Dr. Ziding Feng discussed the link between diabetes and pancreatic cancer, specifically the need for more testing.

Dr. Larry Corey commented on measures enacted to fight COVID-19. 

Dr. Larry Corey reflected on the FDA’s approval of Pfizer’s COVID vaccine in children.

Dr. Larry Corey discussed when 5-11 year olds may receive the vaccine. 

Dr. Josh Schiffer discussed implications for immunity against COVID-19 as SARS-CoV-2 continues to mutate.

Rachel Eguia, a research technician in the Bloom Lab, and Katie Kistler, a graduate student in the Bedford Lab, described SARS-CoV-2’s mutations.

Dr. Rachel Bender Ignacio provided perspective on breakthrough COVID infections.

Dr. Trevor Bedford advocated for updating COVID vaccines against the Delta variant. 

Dr. Rachel Issaka was featured as one of PSBJ's 40 under 40. 

Dr. Jesse Bloom explained how SARS-CoV-2 has changed.

Dr. Larry Corey underscored the safety of COVID vaccines.

Dr. Larry Corey commented on COVID vaccine boosters.

Dr. Rachel Bender Ingacio characterized clinical trial results for molnupiravir.

Dr. Marie Bleakley discussed progress in T-cell receptor therapy. 

Dr. Elizabeth Duke explained the potential of molnupiravir.

Dr. Trevor Bedford commented on being named a 2021 MacArthur Fellow.

Dr. Trevor Bedford reflected on receiving recognition for his research on viral evolution.

Dr. Elizabeth Duke spoke about the promise of an oral antiviral to treat and even prevent COVID.

Drs. Erick Matsen and Trevor Bedford were named Howard Hughes Medical Institute investigators.

Dr. Mark Headley discussed his research on how to make single-cell experiments more efficient.

Dr. Josh Hill commented on a study of Remdesivir in high-risk patients:

Hilary Hehman described the entrepreneurial culture at Fred Hutch that has allowed its commercial endeavors to thrive.

Dr. Trevor Bedford predicted near-term and future spread of SARS-CoV-2.

Dr. Julie McElrath noted that COVID vaccines continue to prevent hospitalization and death.

Dr. Julie McElrath and collaborators from the Allen Institute discussed research in immune response and understanding long COVID.

Dr. Larry Corey noted that vaccine boosters may prevent transmission.

Dr. Scott Ramsey commented on how the standard treatment for sickle cell disease is more costly than a new curative approach.

Dr. Jesse Bloom talked about the evolution of coronaviruses, including SARS-CoV-2.

Dr. Trevor Bedford characterized the landscape of COVID variants.

Dr. Trevor Bedford commented on the volume of COVID genomes now available in the U.S.     

Dr. Riki Peters and collaborators spoke about new research to understand colorectal cancer disparities in Alaska Native people.     

Dr. Larry Corey characterized results from an HIV vaccine study he helped lead.

A new study from Dr. Stan Riddell’s lab shows how to improve CAR T-cell targeting.

Dr. Steve Pergam and Elizabeth Krantz discussed their study on cancer patients and immunity to measles and mumps.

Dr. Holly Janes spoke with NPR.

Dr. Larry Corey discussed COVID vaccine boosters.

Dr. Larry Corey discussed breakthrough cases of COVID.

Dr. Josh Schiffer discussed the rise of variants.

Dr. Steve Pergam and Elizabeth Krantz discussed their study on measles and mumps immunity in cancer patients.

Dr. Steven Pergam and biostatistician Elizabeth Krantz discussed their research on cancer patients and immunity to mumps and measles.

Dr. Tyler Starr discussed his research on SARS-CoV-2 evolution.

Dr. Peter Gilbert explained a study identifying correlates of protection for the Moderna virus.

Dr. Peter Gilbert explained a study identifying correlates of protection for the Moderna virus.

Dr. Peter Gilbert explained a new study identifying correlates of protection for the Moderna vaccine.

Dr. Larry Corey commented on COVID vaccines in immunocompromised people.

Dr. Trevor Bedford commented on the delta variant with The Washington Post.

Allison Greaney, a graduate student in Dr. Jesse Bloom’s lab, discussed her recent study on SARS-CoV-2 immunity.

Dr. Jonathan Bricker shared strategies for quitting smoking.

Dr. Rachel Bender Ignacio explained how small molecule antivirals still work when viruses develop resistance.

Dr. Parth Shah discussed his study on how to encourage HPV vaccination.

Dr. Tom Lynch joined Seattle Cancer Care Alliance, UW Medicine and Seattle Children’s leaders in describing how the new structure will expedite new therapies.

Dr. Tom Lynch described how the restructure of Fred Hutch, UW Medicine, Seattle Children's, and Seattle Cancer Care Alliance could improve startups.

Dr. Jesse Bloom discussed how SARS-CoV-2 will continue to evolve.

Dr. Larry Corey expressed concern about using partial doses of COVID vaccines to increase global access to the vaccines without clinical data.

Dr. Trevor Bedford described the newly emerged Lambda variant.

Dr. Larry Corey shared his reflections on the COVID vaccine program.

Dr. Joe Unger discussed efforts to measure whether changes to clinical trials during the pandemic affected data quality.

Kelly O’Brien shared that Fred Hutch received its first cryptocurrency philanthropic gift. 

Dr. Roberty Bradley discussed a new study that is using experimental compounds that alter RNA to boost the effectiveness of immunotherapy drugs against cancer cells.

Dr. Stephaun Wallace and co-authors wrote an op-ed on the misperceptions around vaccine hesitancy.

Dr. Jesse Bloom’s preprint on recovered sequences of early SARS-CoV-2 cases was featured. 

Dr. Larry Corey commented on a study that is testing whether the Moderna COVID-19 vaccine works to prevent infection and transmission of the virus.

Dr. Stephaun Wallace explained why people who previously had COVID-19 still need to get vaccinated. 

Dr. Larry Corey gave context around COVID vaccine efficacy and durability. He said, “If the duration of protection is such that you can still get a mild cold, but you don't end up in the hospital, the vaccine will still be a success.”

Dr. Steve Henikoff commented on a “landmark” study that adds greater detail of the genome. He said it will enable other research questions, including “What happens in cancer?” and “What happens if you compare offspring to parents?”

In Seattle Gay News’ inaugural podcast, Dr. Stephaun Wallace discussed COVID and HIV vaccine research and engaging communities in science. He said, “One of the things I really appreciate about science is that you’re always learning something.”

Dr. Trevor Bedford reacted to speculation that a clade of the influenza virus may have gone extinct during the pandemic. He said, “I think it has a decent chance that it’s gone. But the world’s a big place.”

Drs. Josh Hill and Steve Pergam discussed COVID immunity among immunocompromised people. Dr. Hill pointed out that for those with weakened immune systems, “Antibody tests are just the tip of the iceberg of what the immune system is doing.”

Dr. Ruth Etzioni characterized how she thinks about the true COVID death toll.

Dr. Trevor Bedford commented on the rise in circulating respiratory viruses as COVID restrictions decrease.

Dr. Peter Gilbert told KIRO 7 about how he is working to find the “correlate of protection."

Drs. Stan Riddell and Shivani Srivastava described research in cell therapies for solid tumors. She said, “All the reasons that make it technically complex are also the reasons why the insights you get are...more likely to be clinically relevant.”

Dr. Jesse Bloom commented on how the 1918 flu virus evolved to become more deadly.

Dr. Rachel Issaka gave insights on the new guidelines for colonoscopies. 

Dr. Michele Andrasik commented on building vaccine confidence.

Dr. Josh Hill emphasized how broad COVID vaccination can “protect our vulnerable patient populations within the community who either can’t get vaccinated for some reason, or who may not have as good of a vaccine response.”

Kelly O’Brien shares how a local milk company is raising money for cancer research. 

Dr. Jesse Bloom commented on a Science letter he wrote with 17 other scientists.

Dr. Josh Schiffer stressed rapid vaccination.

Dr. Chris Li shared results from his study of bisphosphonates and breast cancer.

Dr. Jim Kublin spoke with CNN about next-gen vaccine delivery technologies.

Dr. Holly Janes explained the PreventCOVIDU study of COVID vaccines and transmission.

Drs. Tony Fauci and Larry Corey reflected on their collaboration on HIV and COVID vaccines.

In a profile, Dr. Leah Schmidt talked about her research in Dr. Phil Greenberg’s lab to develop T-cell therapy for lung cancer.

Dr. Rachel Issaka critiqued a study’s consent process.

Dr. Peter Gilbert discussed studies of what immune responses protect against COVID-19.

Drs. Melody Campbell and Barry Stoddard described the newly-opened cryoEM facility.

Dr. Peter Gilbert discussed how to test vaccine protection against SARS-CoV-2 variants.

Dr. Larry Corey commented on the challenge of creating an effective HIV vaccine.

Dr. Stephaun Wallace reflected on his career in public health.

Dr. Larry Corey explained one of the questions the Prevent COVID U study is designed to answer:

Dr. Josh Schiffer spoke with Geekwire and gave his input on SARS-CoV-2 variants.

Bill Gates featured Dr. Stephaun Wallace’s work in his personal blog.

Dr. Jesse Bloom discussed COVID mutations with Bloomberg. 

Drs. Keith Jerome and Martine Aubert won the annual STAT Madness contest for biomedical research.

Allison Greaney of Dr. Jesse Bloom’s lab discussed SARS-CoV-2 virus mutations.

In a Q&A, Dr. Steve Pergam discussed national guidelines on COVID vaccines in cancer patients.

Dr. Josh Schiffer explained his team’s latest analysis of how super-spreader events allow variants to become predominant and create new variants.

Dr. Trevor Bedford commented on advances in the viral genomics field.

Dr. Larry Corey discussed a new study to find out if COVID vaccines prevent transmission.

GeekWire covered Fred Hutch’s Science Says virtual event where Hutch scientists discussed their latest work.

Dr. Joe Unger explained his study showing that in cancer patients, “access to guideline-based care...alone is not sufficient to eliminate disparate outcomes related to socioeconomic deprivation.”

Dr. Larry Corey characterized results from the Antibody Mediated Prevention studies, coordinated through the HIV Vaccine Trials Network, as “important proof of concept” in using antibody infusions to prevent HIV.

In a Q&A, Dr. Josh Hill discussed treating infections in people receiving CAR T-cell therapy.

Dr. Steve Pergam reflected on how public health measures helped reduce spread of other respiratory viruses.

Dr. Josh Schiffer discussed his computational modeling of COVID-19 and a potential fourth wave of infections.

Dr. Laura Matrajt discussed her mathematical models of COVID-19 vaccine distribution.

STAT opinion included reflections on the pandemic from a variety of experts when they realized COVID-19 was here to stay.

Drs. Larry Corey, Josh Schiffer and Trevor Bedford spoke with The Seattle Times about herd immunity.

Dr. Mark Roth discussed his research on suspended animation and how it’s inspired by people who survive near-death experiences.

Dr. Trevor Bedford commented on which variants we should watch and how concerned people should be..

Dr. Josh Schiffer provided context on how the new coronavirus variants makes modeling difficult.

Dr. Josh Hill cautioned that high school sports may be disrupted by COVID-19.

Dr. Andy McGuire discussed findings from the Seattle COVID Cohort Study showing a “massive, massive boost” from the vaccine administered to people who had had COVID.

Drs. Steve Pergam and Michele Andrasik stressed the need for more diversity and inclusion in vaccine clinical trials.

Dr. Tyler Starr discussed how viruses like SARS-CoV-2 evolve and spread through populations of people.

Dr. Trevor Bedford commented on new funding to support genomic surveillance and data collection related to COVID.

Dr. Stephanie Lee discussed how cancer treatment can be adjusted due to the pandemic.

Dr. Peter Gilbert described measuring immune responses to vaccines as a way of testing their efficacy.

Dr. Larry Corey gave his thoughts to Business Insider about SARS-CoV-2 becoming endemic.

Dr. Stephanie Lee discussed new clinical trial results.

A new company called Ensoma launched based on research from Dr. Hans-Peter Kiem’s lab. The company is developing gene editing treatments, gene therapies and gene regulators.

In an op-ed, Dr. Josh Schiffer advocated for increased masking to limit the COVID-19 pandemic.

Drs. Jesse Bloom and Tyler Starr are highlighted in The National Institutes of Health's Director's Blog about which coronavirus variants will resist antibody treatment.

Dr. David Maloney commented on the FDA approval of a CAR T-cell therapy developed in part at Fred Hutch.

Dr. Heather Greenlee described her goal for the Cook for Your Life website.

Dr. Rachel Bender Ignacio stressed the need for treatments as COVID-19 likely becomes endemic.

Dr. Larry Corey gave his insight on the pause in rolling out the AstraZeneca vaccine in South Africa. 

Dr. Steve Pergam explained why people should get their COVID-19 vaccines from the same provider.

Dr. Larry Corey was quoted in The Washington Post on the potential for reinfection from some variants.

Dr. Josh Schiffer shared his prediction of what the next wave of the coronavirus pandemic could look like.

Dr. Catherine Liu commented on emerging recommendations for cancer patients receiving COVID-19 vaccines.

Dr. Tyler Starr discussed his research on predicting possible mutations to SARS-CoV-2, including one that is now part of the variant called B.1.1.7.

Dr. Larry Corey reflected on results from the Antibody Mediated Prevention study.

Dr. Trevor Bedford weighed in on modeling that predicted lifting public health guidelines in February could cause 29 million additional coronavirus cases by July.

Dr. Larry Corey discussed the global significance of the upcoming Janssen vaccine trial results.

Dr. Larry Corey stressed that to slow the spread of variants of concern, as we expand access to COVID-19 vaccines, “We have to do everything we can to decrease the risk of transmission and acquisition.”

Dr. Stephaun Wallace explained how mobile sites can increase vaccination rates among communities of color.

The story quoted tweets from Dr. Trevor Bedford, in which he noted that “The fact that we’ve observed three variants of concern emerge since September suggests that there are likely more to come.”

Drs. Pavitra Roychoudhury, Jesse Bloom and Trevor Bedford commented on efforts to track SARS-CoV-2 variants.

Dr. Trevor Bedford estimated that with a more transmissible variant, “It makes the same situations that generate spread now — people living in the same household, these sorts of non-ventilated indoor contacts — to be more likely to spread.”

Dr. Thomas Lynch described the gratification of improving lung cancer death rates in the US.  

Dr. Trevor Bedford explained that the lack of flu virus genomes will make it difficult to select strains for next season’s flu vaccine.

Dr. Fabian Cardozo-Ojeda described the collaboration that went into utilizing models to potentially cure HIV through stem cell transplants.

Dr. Larry Corey discussed why COVID vaccine Phase 3 trials focused on finding out if the vaccines reduced severe disease and didn’t measure transmission.

Dr. Larry Corey commented on the limited data about whether COVID vaccines prevent transmission.

Dr. Rachel Issaka described how patients should approach at-home colon cancer tests with their doctors.

Dr. Laura Matrajt discussed her computer model that showed the benefit of administering one-dose vaccines to end the pandemic.

Dr. Jesse Bloom discussed his latest paper about coronavirus mutations and their implications for vaccine efficacy.

Dr. Trevor Bedford predicted the SARS-CoV-2 variant of concern “to go from initial arrivals in the U.S. in December to starting to kind of dominate the virus population in, say, March.”

Kathy Alexion shared some of her top priorities for 2021 as Fred Hutch’s Chief Information Officer

Allison Greaney of Dr. Jesse Bloom’s lab described their study of 4,000 SARS-CoV-2 mutations.

Research nurse Corrie Moreau described her motivation for being involved with COVID-19 therapy studies.

Infectious disease reporter Helen Branswell recalled an interview with Dr. Trevor Bedoford about SARS-CoV-2 in early 2020.

Dr. Rachel Bender Ignacio emphasized the importance of COVID-19 treatment studies.

Dr. Jesse Bloom cautioned not to overly concerned about a new coronavirus strain and how dangerous it could be.

Dr. Steve Pergam shared the importance of COVID-19 prevention measures for cancer patients.

Dr. Josh Schffer emphasized why it’s important to understand if COVID-19 vaccines prevent asymptomatic infections and transmissions.

Evolutionary biologist Dr. Jesse Bloom discussed how viruses mutate.

Drs. Jesse Bloom and Trevor Bedford discussed implications of SARS-CoV-2 mutating.

Dr. Jim Boonyaratanakornit shared guidance for cancer patients and COVID-19 vaccines. 

Dr. Larry Corey commented on the diverse populations that were enrolled in the Moderna vaccine study.

Dr. Jim Kublin reflected on progress in developing COVID-19 vaccines:

Drs. Michele Andrasik and Adrienne Shapiro emphasized the disproportionate impact of COVID-19 on communities of color.

Dr. Larry Corey underscored the benefit of COVID vaccines.

Dr. Rachel Bender Ignacio discussed a machine learning approach that could help identify drugs to treat COVID-19.

Dr. Josh Hill shared guidance for cancer patients and the COVID-19 vaccine.  

Dr. Scott Ramsey discussed how some of the changes to health care during the pandemic may result in improved quality of care and greater efficiency.

Dr. Anne McTiernan provided expert commentary on the myths and benefits of Vitamin D.

Fred Hutch fundraiser Bruce Haldors summarized his efforts to support a cancer patient through a holiday light display.

The New Yorker gave updates on vaccine trials and the first vaccines to get emergency approval.

Kelly O’Brien described how this year’s holiday gala is changing due to the COVID-19 pandemic.

Dr. Josh Hill shared insight into the CDC’s new guidelines around quarantining after exposure to COVID-19.

Dr. Holly Janes discussed biostatistical implications of having placebo-treated volunteers offered the vaccine.

Dr. Larry Corey spoke about the challenge of continuing to test some COVID vaccines, even as effective ones emerge.

Dr. Larry Corey characterized the latest data on Moderna’s COVID-19 vaccine candidate. 

Dr. Larry Corey outlined a new plan to test if COVID-19 vaccines prevent infection.

Dr. David Maloney discussed advances in cell therapies and what it means for blood cancer patients.

Dr. Holly Janes discussed the importance of large clinical trials for assessing safety of vaccine candidates.

Dr. Trevor Bedford confirmed his assessment that scientific evidence shows the 614G variant of SARS-CoV-2 is more easily transmitted. 

In a Q&A about her position as ASH president, Dr. Stephanie Lee encouraged others to pursue leadership roles.

Dr. Josh Schiffer authored an opinion piece urging Americans to take proper COVID-19 measures.

Dr. Trevor Bedford predicted that U.S. COVID-19 deaths could reach 2,000 a day within weeks, and that “Importantly, this doesn’t assume any further increases in circulation and is essentially ‘baked into’ currently reported cases.”

Dr. Laura Matrajt discussed how her computer modeling studies on vaccine distribution strategies have adapted with the pandemic.

Dr. Larry Corey summarized the role Fred Hutch and the COVID-19 Prevention Network is playing during the pandemic. 

Dr. Josh Schiffer detailed why the MLS may face more COVID-19 related cancellations.

Dr. Soheil Meshinchi discussed how computational tools are revealing how to best match cancer therapies for patients.

Dr. Steve Pergam stressed the need for families to rethink holiday gatherings during the COVID-19 pandemic.

Dr. Larry Corey reflected on the speed of COVID-19 vaccine development. 

Dr. Julie McElrath explained that her team is working to enroll people who “are over 65 years old, those who may have some kind of underlying medical conditions such as heart disease, high blood pressure, diabetes” into the Fred Hutch vaccine trial.

Dr. Julie McElrath discussed several COVID vaccines being tested in phase 3 trials in the Seattle area. 

GeekWire detailed the cancer research projects within the Fred Hutch-led Cascadia Data Alliance.

The New York Times magazine’s “Studies Show” featured Dr. Laura Matrajt’s vaccine modeling preprint paper. 

Dr. Rachel Issaka spoke with KING 5 about how structural racism affects both doctors of color and patients. 

Dr. Andrew Hsieh thanked a former postdoc for inspiring his lab’s “most scientific” pumpkin in Fred Hutch’s annual contest.

Dr. Rachel Bender Ignacio emphasized the importance of studies at the COVID-19 Clinical Research Center.

Dr. Steve Pergam underscored the importance of taking COVID-19 precautions during the holidays.

Kathy Briant summarized the importance of equity in cancer care and discussed Fred Hutch’s community outreach work

Dr. Trevor Bedford reflected on how the pandemic “will leave us with generally strengthened surveillance systems and public health, and an ability to deal with something like this in the future to a better degree.”

Dr. Larry Corey touted the expertise Fred Hutch brings to coordinate COVID-19 vaccine trials.

Dr. Larry Corey reflected on full enrollment in the first Phase 3 vaccine trial.

Dr. Stephanie Lee discussed disparities in blood cancer treatment and survival rates.

Dr. Jesse Bloom’s recent study of cases aboard a fishing boat provided evidence that antibodies protect against COVID-19.

Dr. Larry Corey discussed how the COVID-19 Prevention Trials Network has supported enrolling diverse populations into COVID-19 vaccine trials.

Dr. Thomas Lynch described why he’s excited about the opening of the Lake Union Steam Plant.

Dr. Josh Hill discussed treating immune responses in COVID-19 patients.

Dr. Kevin Cheung noted epigen’s role in the spread of breast cancer.

Fred Hutchinson Cancer Research Center Research announced Monday that it has opened its COVID-19 Clinical Research Center.

In an op-ed piece, Dr. Josh Schiffer suggested COVID-19 strategies can be flawed but still effective in reducing transmission.

Drs. Shelly Karuna and Larry Corey commented on the potential of monoclonal antibodies to treat and prevent COVID-19.

In a Q&A, Dr. Rachel Issaka discussed how health care professionals can dismantle systemic racism in medicine, including examining “the policies and structures within medicine that make it more difficult for minority patients to thrive.”

Dr. Alpana Waghmare described why Fred Hutch's CovidWatch study is now available for Spanish-speaking volunteers.

Dr. Katherine Lalish described the qualities that make Fred Hutch intern Nicole Magaki a fitting “Junior Geek of the Month.”

Dr. Trevor Bedford reflected on discovering the first case of community transmission in the region in this comic feature.

Dr. Chris Li described how obesity is driving an increase in cancer rates.

Dr. Jonathan Bricker explained how acknowledging and accepting cravings is the key to quitting smoking.

Dr. Steve Pergam described how the COVID-19 pandemic could impact other infections.

Dr. Trevor Bedford spoke about the early cases of COVID in the U.S.

Dr. Daniel Reeves described how increased masking is the key to lowering COVID-19 transmissions.

Rev. Edwin Sanders, a faith ambassador with the CoVPN Faith Initiative, characterized his approach with his community and congregation.

Dr. Larry Corey discussed the importance of conducting vaccine trials to the highest scientific standards. 

Dr. Anne McTiernan explained the limitations of studying hair dye and cancer risk.

Dr. Larry Corey discussed the purpose of CoVPN’s national ad campaign.

Dr. Fred Appelbaum discussed policies to keep clinical trials for cancer moving forward during COVID-19.

In an FAQ about vaccine trial statistics, Holly Janes explained how the COVID-19 trials are based on how many cases of the disease.

Holly Janes explained statistics of COVID-19 vaccine trials.

Dr. Jim Kublin discussed the need for volunteers in the COVID-19 clinical trial registry.

Dr. Trevor Bedford was selected for Fortune’s 40 under 40 in the healthcare category.

Dr. Keith Jerome discussed the importance of his new paper showing a 90% reduction of latent herpes virus.

Dr. Tyler Starr discussed how viruses mutate and what that means for SARS-CoV-2.

Dr. Rachel Issaka commented on the importance of home screening tests for colorectal cancer.

Dr. Dobromir Dimitrov provided outside commentary on a new model focused on safely reopening schools.

Dr. Josh Schiffer provided outside commentary on a new study looking at a COVID-19 superspreading event in Boston.

Dr. Keith Jerome discussed his new study showing how gene editing removed 90% of herpes in mice.

Peter Gilbert discussed vaccine clinical trial design in a story about national efforts to rapidly find a safe and effective vaccine.

Dr. Josh Schiffer described the role T-cells play in COVID-19 immune responses.

USA Today covered the need for diversity in COVID-19 vaccine trials, mentioning Fred Hutch and the CoVPN.

In a study in Science, Fred Hutch researchers with collaborators at UW’s Institute for Protein Design found a way to kill only “the cells with the desired combinations of surface markers.”

Dr. Larry Corey commented on how discussions are underway to include pregnant women and children in COVID-19 vaccine trials.

The New York Times reported on a study addressing whether previous COVID-19 infection protects from reinfection, quoting a Tweet from co-author Jesse Bloom, “Knowing the answer to this question is critical for vaccine design and epidemiology.”

Fred Hutch scientists described their new analysis on safely reopening schools.

Dr. Elizabeth Halloran discussed the design of vaccine clinical trials and shared information on how people can register as a volunteer..

Dr. Steve Pergam raised concerns about how unnecessary COVID-19 testing could lead to negative behaviors.

Dr. Julie McElrath discussed the benefits of working with the Allen Institute for COVID-19 research.

A profile of Dr. Larry Corey and his role leading operations for the CoVPN.

Dr. Julie McElrath’s work with the Allen Institute to understand the characteristics of an effective COVID-19 immune response was covered by GeekWire. 

Dr. Josh Schiffer described how to prevent COVID-19 superspreader events

Dr. Josh Schiffer shot down the idea of achieving natural herd immunity for COVID-19.

Dr. Steve Pergam raised concerns over MLS matches resuming.

Dr. Josh Schiffer emphasized the importance of “superspreader” events and COVID-19.  

Kaiser Health News explored issues of vaccine efficacy in obese individuals, quoting Dr. Larry Corey.

Jim Birrell shared the community’s excitement for this year’s Obliteride.

Dr. Larry Corey explained aspects of participating in a COVID-19 vaccine trial.

Dr. Anne McTiernan outlined how Vitamin D impacts weight.

Dr. Steve Pergam described the importance of getting flu shots, especially for protecting babies, older people and others with compromised immune systems. 

Dr. Steve Pergam expressed concerns over COVID-19 testing and the impact on underrepresented populations.

Dr. Larry Corey emphasized the need for COVID vaccine data in pregnant women to find what is the safest vaccine for them.

Kelly O’Brien shared how the COVID-19 pandemic isn’t hurting Obliteride participation.

Dr. Jim Kublin answered questions about the CoVPN program, the challenges of the program and more. 

South Seattle Emerald covered the region’s important role in testing potential COVID vaccines.

Dr. Larry Corey explained CoVPN’s focus on including people at most risk for COVID-19 in the vaccine trials, specifically minorities and people with comorbidities. 

Michele Andrasik spoke about the priorities of CoVPN and the COVID-19 vaccine trials. 

GeekWire mentioned Fred Hutch’s planned expansion into the Steam Plant. 

Stephaun Wallace spoke about the barriers to clinical trial enrollment in Black, Latino and other minority populations, and the strategies to encourage those populations to participate in clinical trials. 

Dr. Larry Corey discussed CoVPN trial enrollment goals in terms of reaching a diverse, multigenerational population.

Michele Andrasik discussed how outreach methods may need to differ depending on the communities that researchers are trying to reach with COVID-19 trials. 

Ruth Etzioni weighed in on how family interactions can be a large source of COVID-19 spread to at risk populations. 

Dr. Joshua Schiffer predicted what may happen if the U.S. tries to achieve herd immunity without a COVID-19 vaccine. 

Dr. Jim Kublin discussed the CoVPN program, trial recruitment and vaccine development. 

Dr. Matthias Stephan talked about his methodology to deliver immune cells to tumors with thin metal mesh, which won Health Innovation of the Year in the 2020 GeekWire awards. 

Dr. Steve Pergam weighed in on what we can do now to slow COVID-19, emphasizing physical distancing measures, PPE, test and tracing plans and masking.  

Trevor Bedford’s work and comments on COVID-19 from the beginning of the pandemic are referenced.

KING 5 described how Fred Hutch’s Obliteride is changing formats in response to the COVID-19 pandemic.

Stephaun Wallace discussed the details of the CoVPN clinical trials and the focuses of the program. 

Trevor Bedford discussed his work with Nextstrain and the start of tracking COVID-19 in Seattle. 

Anne McTiernan provided information on ways to reduce breast cancer risk, including reducing alcohol intake. 

Keith Jerome’s antibody work and antibody study results from the Fred Hutch campus are discussed.

Dr. Larry Corey’s comments saying a vaccine that is safe and works in at least 50% of people would be viable are discussed. 

Forbes covered the CoVPN program, its goals and how the network will be run. 

Dr. Ryan Cassaday spoke about alternative to CAR T-cell therapies and the benefits of other treatments. 

Stephaun Wallace provided information about the CoVPN network, specifically the call for diverse applicants across ethnic, racial, occupational groups and ages. 

Dr. Jim Kublin explained the CoVPN network, and the goals of the program. 

Dr. Rachel Issaka discussed her recent essay on structural racism in academic medicine, and what should be done to change it. 

Dr. Steve Pergam shares tips to reduce the infection risk of COVID-19. 

Dr. Larry Corey is mentioned for comments on the CoVPN registry, and the call for diverse trial participants. 

Tyler Starr commented on the possibility of a SARS-CoV-2 mutation causing the virus to be more infectious.

Comedian Joel McHale spoke about his conversations on COVID-19 with Dr. Joshua Schiffer.

Dr. Larry Corey discussed how building the HIV trial network laid the foundation for CoVPN.

Research from Fred Hutch indicating the COVID-19 infection rate in Washington is increasing above peak levels from March is referenced. 

Susan Bullman commented on an outside study suggesting certain microbial signatures in blood are associated with cancer.

Dr. Joshua Schiffer commented on the trend of younger people getting COVID-19 and their risks. 

The CoVPN announcement is covered by KING 5.

Julie Czartoski explained the goals of the COVID cohort study and the value of enrolling first responders like firefighters. 

Julie Czartoski discussed testing the Everett’ Fire Station as part of the COVID cohort study. 

Dr. Jim Kublin commented on the timeline and goals of the CoVPN network.

Trevor Bedford discussed his work on SARS-CoV-2 genomic epidemiology using twitter for science outreach and communications. 

Dr. Larry Corey discussed the CoVPN network, how the vaccine trials will be run and his role in the program. 

Dr. Larry Corey discussed how the CoVPN trial network will work and the goals of the program. 

Forbes covered the CoVPN announcement and Fred Hutch’s role in the network of clinical trials. 

Dr. Larry Corey commented on the role Fred Hutch will take in developing coronavirus vaccines, building off of work with HIV vaccines.

CNN covered the announcement of the CoVPN network, of which Fred Hutch will serve as the coordination center and Dr. Larry Corey as the lead. 

Dr. Steve Pergam commented on the restarting of professional sports in July, reinforcing that it may be necessary to stop if COVID-19 cases rise. 

Trevor Bedford weighed in on new findings suggesting COVID-19 was spreading in New York City in early February. 

Trevor Bedford explained how Nextstrain and genomic epidemiology can inform public health and discussed the COVID-19 pandemic. 

Dr. Keith Jerome and Trevor Bedford explained the rise in positive COVID-19 tests, indicating a rise in infections rather than false positives. 

Dr. Julie McElrath discussed the COVID Cohort study to gather information on first responders and those who are likely to be exposed to the virus. 

Joseph Unger commented on his new study on the impact of insurance status on health outcomes. 

Dr. Catherine Liu commented on COVID-19 and cancer patients, and the risk for more severe infection. 

The announcement of new board chair Kathy Surace-Smith and vice chair Leigh Morgan, along with two new board members, Dr. Connie Kravas and Pete Shimer, is covered by GeekWire. 

The announcement of a new board chair and vice chair, along with two new board members is covered. 

Elizabeth Halloran commented on the lack of clarity in COVID-19 infection case counts, suggesting the total number is much higher than current estimates. 

Dr. Larry Corey explained ‘Operation Warp Speed’ for developing COVID-19 vaccines, and the safety and efficacy standards of the program. 

The New York Times recapped the COVID-19 pandemic, referencing Trevor Bedford’s work tracking the virus through Nextstrain and the Seattle Flu Study.

Joseph Unger’s and the SWOG network's latest research illustrating that Black patients are better represented in publicly funded cancer clinical trials is discussed. 

Joe Unger commented on how a lack of Black patients in clinical trials can lead to a lack of data on how drugs impact vulnerable populations. 

Dr. Steve Pergam weighed in on the potential impact of reopening restaurants, loosening other restrictions, and protests on COVID-19 infection rates. 

Dr. Joshua Schiffer’s new review paper, with co-authors from Fred Hutch and UW, suggesting that an early test and treat strategy is the best way to control COVID-19, is covered. 

 A review article by Dr. Joshua Schiffer on ways to keep COVID-19 from getting out of control again is covered, highlighting the need for widespread testing and treatment early in diagnosis. 

Dr. Joshua Schiffer’s new article emphasizing the need for widespread testing and early treatment for COVID-19 is discussed. 

Data on COVID-19 infection rates from Fred Hutch, suggesting the infection rate in Washington State has risen, is referenced. 

Dr. Steve Pergam weighed in on the risks of starting up the NBA season during COVID-19. 

Dr. Joe Unger’s research with the SWOG network suggesting health insurance plays a role in clinical trial success for patients is discussed. 

Dr. Larry Corey discussed COVID-19 vaccine trials and the challenges involved. 

Brooks announced the Brave Like Gabe shoe, in honor of Gabriele Grunewald, where proceeds will go to a researcher at Fred Hutch. 

Yuan Tian explained how inflammation factors into COVID-19, and the need for further studies on immune cells. 

The Brave Like Gabe shoe launch, with proceeds going to a Fred Hutch researcher, is profiled. 

Dr. Larry Corey explained the complexities of COVID-19 vaccine trial setup and development. 

Trevor Bedford and Allison Black discussed a paper they co-authored on how to build a scientific ecosystem that is better equipped to tackle COVID-19.

Ruth Etzioni explained the predicted COVID-19 infection trends for the fall, suggesting infections will increase. 

Fred Hutch is mentioned for involvement in an HIV and COVID-19 study team, to determine if patients with HIV are at higher risk of more severe infection. 

Dr. Larry Corey discussed COVID-19 vaccine trials, the timelines, and how they will be structured. 

Trevor Bedford’s tweets on COVID-19 and protesting are referenced.

A Fred Hutch study on the relationship between breast cancer and deodorant use is cited.

Trevor Bedford’s estimates of COVID-19 infections resulting from protests are referenced. 

Trevor Bedford’s tweets on estimates of COVID-19 infection rates after protests in the U.S. are referenced. 

Dr. Larry Corey and Dr. John Mascola’s webinar on COVID-19 vaccine development is quoted, specifically that vaccine development will require coordination from all industries. 

A  Fred Hutch webinar featuring Dr. Larry Corey and Dr. John Mascola of NIAID on COVID-19 vaccine development is recapped by GeekWire. 

Laura Matarajt explained how and why physical distancing works to help prevent the spread of COVID-19.

Ruth Etzioni weighed in on the potential impact of the protests on COVID-19 cases and policies. 

Medium referenced the CovidWatch program as part of Amazon’s role in COVID-19 response. 

Yuan Tian discussed the value that further research on T-cell responses in people with severe and mild COVID-19 infection could provide, in light of an outside study showing immune response in those without exposure. 

Fred Hutch President and Director Dr. Tom Lynch spoke with Fierce Biotech about his new role, the Hutch’s scientific priorities and COVID-19. 

Dr. Joshua Schiffer weighed in on the safety of travel during the COVID-19 pandemic, and possible ways to keep infection risk low. 

Trevor Bedford discussed his COVID-19 research, the test, trace, isolate strategy and next steps to reopen. 

Jesse Bloom and colleagues explained results of a recent study showing 1% of children tested had COVID-19 antibodies, about at the same rate as adults. 

Trevor Bedford commented on the possibility of COVID-19 infection in early January, suggesting it was likely flu. 

Dr. Steve Pergam commented on the need for public health to be driven by science and the value of the CDC. 

Dr. Gary Lyman’s work with the COVID-19 and Cancer Consortium is referenced, revealing that patients with active cancer have a higher risk of death after contracting SARS-CoV-2. 

New research from the Hutch's health economics group HICOR and Dr. Veena Shankaran, suggesting nearly 75% of patients with advanced colon cancer experience financial hardship as a result of treatment is discussed. 

Trevor Bedford is quoted on an updated analysis suggesting the WA1 COVID-19 patient was not the initial start to the outbreak in Washington. 

Allison Black explained COVID-19 contact tracing apps, and how they can be leveraged to slow COVID-19 spread. 

Louise Moncla discussed new research suggesting a second introduction of COVID-19 led to the outbreak in Washington. 

The first virtual Hutch Award ceremony and winner Dee Gordon are profiled. 

The Hutch Award and 2020 winner Dee Gordon are profiled, specifically his philanthropic work and how he got into baseball. 

Trevor Bedford discussed his updated analysis suggesting the COVID-19 outbreak began in Seattle in February.

Trevor Bedford’s analysis of COVID-19 genomes suggesting Washington’s outbreak came from an alternative source than the original patient is referenced. 

Trevor Bedford’s tweets on the start of the COVID-19 outbreak in Washington and patient WA1 are discussed. 

Dr. Larry Corey is quoted on COVID-19 vaccine development progress.  

Louise Moncla commented on mutations in SARS-CoV-2 and the lack of knowledge around the impact they have on the virus. 

President Dr. Thomas Lynch discussed Fred Hutch’s work related to COVID-19 virology, epidemiology and vaccine programs. 

Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19.

Dr. Larry Corey suggested potential timeframes for the development of a COVID-19 vaccine. 

Dr. Larry Corey discussed the current status of COVID-19 vaccine trials. 

Allison Black weighed in on COVID-19 contact tracing apps and the features they need to be effective. 

Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19, saying more research is needed. 

President Dr. Thomas Lynch explained the work Fred Hutch is doing on COVID-19 research and vaccines. 

Dr. Larry Corey is quoted for the announcement of COVID-19 vaccine trials. 

Dr. Elizabeth Halloran explained how we can use COVID-19 models to our advantage, and her recent modeling work and some of the caveats of model predictions. 

Trevor Bedford is quoted on the lack of full COVID-19 suppression in the U.S. and the implications on further physical distancing policies. 

Trevor Bedford is listed for receiving a Webby Special Achievement award for Nextstrain. 

Dr. Thomas Lynch and his live virtual chat with GeekWire are highlighted. 

Bloomberg cited the CovidWatch study as one of the ways Amazon is working to stop COVID-19. 

Dr. Larry Corey explained COVID-19 vaccine strategy and the current status of research around COVID-19 in this video interview with Science. 

Dr. Steve Pergam commented on the shutdown of SCAN by the FDA. 

Dr. Keith Jerome discussed COVID-19 virology, the possibility of reinfection, and transmission. 

Trevor Bedford’s comments on the COVID-19 status and lack of viral suppression in the U.S. are referenced. 

The Covidwatch study is profiled, with Dr. Michael Boeckh explaining the study goals. 

Dr. Nancy Davidson described plans to reopen SCCA safely as COVID-19 cases decline in Washington. 

Dr. Trevor Bedford weighed in on when COVID-19 arrived in the U.S., the origins of the virus, and more. 

Dr. Elizabeth Halloran discussed COVID-19 testing, strategy, and modeling with other biostatisticians and epidemiologists studying the virus. 

Dr. Joshua Schiffer commented on the feasibility of staying safe from COVID-19 in large group gatherings such as concerts. 

Steven Heinkoff explained his at home CUT&Tag protocol and how he was able to bring his lab work home. 

Trevor Bedford’s genomic analysis exploring the spread of COVID-19 across the U.S. is highlighted, along with Nextstrain. 

KIRO 7 covered the CovidWatch program, led by Dr. Michael Boeckh, which aims to better understand COVID-19. 

Ruth Etzioni explained the complications of COVID-19 modeling and the issues with the predictions they can make. 

Dr. Monica Thakar commented on her work using natural killer cells to target solid tumors. 

The SCAN program is explored, specifically it’s challenges and goals to track COVID-19 spread. 

Dr. Larry Corey discussed COVID-19 vaccine development and clinical trials. 

The SCAN Initiative and the role of Gates Ventures in the program are discussed. 

Dr. Larry Corey commented on COVID-19 vaccine trials and strategy. 

Business Insider referenced an editorial piece co-written by Drs. Larry Corey, Anthony Fauci and other experts on COVID-19 vaccine development. 

The SCAN initiative is profiled by Gates Notes, mentioning Fred Hutch as a partner. 

The SCAN initiative and Gates Notes article on the program are discussed. 

Dr. Larry Corey’s co-authored editorial in Science, explaining a roadmap to a COVID-19 vaccine and calling for a variety of approaches and collaboration, is discussed. 

The Science piece co-authored by Drs. Larry Corey, Anthony Fauci, Francis Collins and John Mascola is cited.

Dr. Larry Corey is quoted on the need for collaboration and multiple COVID-19 vaccines, in relation to the release of a co-authored piece on COVID-19 vaccine development in Science. 

GeekWire highlighted a Bank of America grant that will fund Fred Hutch COVID-19 response and the purchase of medical supplies for SCCA. 

GeekWire featured Dr. Larry Corey’s Science perspective, co-authored with Drs Anthony Fauci, John Mascola and Francis Collins, on proposed COVID-19 vaccine plans.

KOMO profiled the COVIDWatch study led by Dr. Michael Boeckh to track COVID-19 in the population.

Trevor Bedford’s discovery of COVID-19 community spread through the Seattle Flu Study is referenced. 

Dr. Larry Corey is discussed along with the co-authors Drs. Anthony Fauci, John Mascola and Francis Collins, on a Science perspective piece on the development of a COVID-19 vaccine. 

Allison Black is mentioned for a segment where she discussed COVID-19 tracking and her work in the Bedford lab. 

Dr. Keith Jerome is quoted on the impact that early physical distancing measures had in lowering COVID-19 rates in Washington. 

Bloomberg quoted Trevor Bedford on statements suggesting that further research is needed to determine if one COVID-19 strain is more transmissible than others. 

A SWOG study led by Joseph Unger is featured, specifically findings that insurance plays a large role in whether a patient benefits from clinical trials.

Dr. Jim Olson’s work with tumor paint to identify cancerous tissue and the motivation behind his research are discussed. 

Dr. Elizabeth Halloran explained how easily accessible and repeated testing, contract tracing and isolation when sick could keep COVID-19 under control without a vaccine. 

Trevor Bedford weighed in on serology testing, the true COVID-19 incidence in the U.S., and how we could use blood samples to retroactively test for COVID-19. 

Dr. Elizabeth Halloran discussed the need for increased COVID-19 testing and contact tracing to justify loosening physical distancing measures

Trevor Bedford’s statements on the implications of a mutation in SARS-Cov-2’s spike proteins are referenced. 

STAT covered the new COVIDWatch study and partnership with Amazon, aimed at learning more about COVID-19’s infection rate and if infection confers immunity. 

Dr. Ruth Etzioni explained the intricacies of modeling and how that relates to COVID-19 predictions. 

Dr. Steve Pergam criticized those neglecting to follow physical distancing restrictions. 

Dr. Josh Schiffer explained the complexity of COVID-19 immune response and variability across patients. 

Dr. Ruth Etzioni commented on the IHME model and conclusions being drawn from that model.

Business Insider discussed Nextstrain work and Trevor Bedford’s comments on COVID-19 lineages and the unknown impact on transmissibility. 

Trevor Bedford’s commentary on a COVID-19 spike mutation is referenced, suggesting we don’t know the impact of the mutation on transmissibility. 

Trevor Bedford stated that it’s not possible SARS-CoV-2 was circulating in the U.S. in or before November 2019.

Trevor Bedford’s statements on the impacts of a SARS-Cov-2 mutation are cited, saying we need further research to determine if it impacts transmissibility. 

Trevor Bedford’s statements predicting continued COVID-19 infections across the U.S. are cited. 

Kelly O’Brien discussed COVID-19 and the value of giving to scientific progress. 

Trevor Bedford’s commentary on the lack of accuracy of some COVID-19 antibody tests is included.